Style | Citing Format |
---|---|
MLA | Parizi PK, et al.. "Evaluation of the Association Between Centrosome Amplification in Tumor Tissue of Breast Cancer Patients and Changes in the Expression of Cetn1 and Cntrob Genes." Gene Reports, vol. 26, no. , 2022, pp. -. |
APA | Parizi PK, Seresht LM, Esmaeili SA, Jazi AD, Sarli A, Khosravian F, Salehi M (2022). Evaluation of the Association Between Centrosome Amplification in Tumor Tissue of Breast Cancer Patients and Changes in the Expression of Cetn1 and Cntrob Genes. Gene Reports, 26(), -. |
Chicago | Parizi PK, Seresht LM, Esmaeili SA, Jazi AD, Sarli A, Khosravian F, Salehi M. "Evaluation of the Association Between Centrosome Amplification in Tumor Tissue of Breast Cancer Patients and Changes in the Expression of Cetn1 and Cntrob Genes." Gene Reports 26, no. (2022): -. |
Harvard | Parizi PK et al. (2022) 'Evaluation of the Association Between Centrosome Amplification in Tumor Tissue of Breast Cancer Patients and Changes in the Expression of Cetn1 and Cntrob Genes', Gene Reports, 26(), pp. -. |
Vancouver | Parizi PK, Seresht LM, Esmaeili SA, Jazi AD, Sarli A, Khosravian F, et al.. Evaluation of the Association Between Centrosome Amplification in Tumor Tissue of Breast Cancer Patients and Changes in the Expression of Cetn1 and Cntrob Genes. Gene Reports. 2022;26():-. |
BibTex | @article{ author = {Parizi PK and Seresht LM and Esmaeili SA and Jazi AD and Sarli A and Khosravian F and Salehi M}, title = {Evaluation of the Association Between Centrosome Amplification in Tumor Tissue of Breast Cancer Patients and Changes in the Expression of Cetn1 and Cntrob Genes}, journal = {Gene Reports}, volume = {26}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Parizi PK AU - Seresht LM AU - Esmaeili SA AU - Jazi AD AU - Sarli A AU - Khosravian F AU - Salehi M TI - Evaluation of the Association Between Centrosome Amplification in Tumor Tissue of Breast Cancer Patients and Changes in the Expression of Cetn1 and Cntrob Genes JO - Gene Reports VL - 26 IS - SP - EP - PY - 2022 ER - |